🇺🇸 FDA
Patent

US 7906555

Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance

granted A61KA61K31/196A61K31/24

Quick answer

US patent 7906555 (Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/196, A61K31/24, A61K31/341, A61K31/4402